Ven­du! Weeks af­ter Sanofi cuts ties to Al­ny­lam, the phar­ma gi­ant of­floads $842M of its stock

Sanofi has cut its last re­main­ing link with Al­ny­lam, 5 years af­ter the two first be­gan their col­lab­o­ra­tion and just weeks since the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.